Pharma

Anthony Giovinazzo Receives the 2017 Bloom Burton Award

Anthony Giovinazzo Receives the 2017 Bloom Burton Award TORONTO, September 19, 2017 – Bloom Burton & Co. (“Bloom Burton”), Canada’s leading healthcare-specialized investment banking firm, is pleased to announce Anthony Giovinazzo as the recipient of the inaugural Bloom Burton Award. Mr. G ...

Canaccord Genuity raises price target on Oncolytics Biotech to $2.50

Oncolytics Biotech CEO Matt Coffey The end of Oncolytics Biotech (TSX:ONC, Nasdaq:ONCY) phase two meetings with the FDA have derisked the story, says Canaccord Genuity analyst Neil Maruoka. This morning, Oncolytics Biotech announced it had completed the successful end of its phase two meeting wit ...

Drug Patent Expirations for Sep 14, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION (fexofenadine hydrochloride; pseudoephedrin ...

Mackie Research lowers price target on Cardiome Pharma

The licensing of a new product isn’t enough for Mackie Research Capital analyst André Uddin to maintain his enthusiasm for Cardiome Pharma (TSX:COM, Nasdaq:CRME) in the face of falling comparables. This morning, Cardiome announced it had reached an agreement with Basilea to distribute and licen ...

CanniMed Therapeutics has 56% upside, says Echelon Wealth

A third quarter that was better than he expected has Echelon Wealth Partners analyst Russell Stanley feeling confident about his price target on CanniMed Therapeutics (TSX:CMED). This morning, CanniMed reported its Q3, 2017 results. The company lost $1.35-million on revenue of $4.8-million, a topli ...

Drug Patent Expirations for Sep 7, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. SYMLIN (pramlintide acetate) Astrazeneca Ab Patent number: 6,114,304 Expirati ...

Just how big is the hepatitis C market in the United States?

This is a guest post from Rick Shalvoy, CEO, Consumer Health Education Programs The recent FDA approval of AbbVie’s Mavyret™  DAA (direct-acting antiviral) treatment for HCV (hepatitis C virus) has sparked any number of news stories about the beginning of a new “price war” between AbbVie ...

Drug Patent Expirations for Aug 31, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. RELPAX (eletriptan hydrobromide) Pfizer Ireland Patent number: 6,110,940 Expi ...

Drug Patent Expirations for Aug 24, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. SAXENDA (liraglutide recombinant) Novo Nordisk Inc Patent number: 7,235,627 E ...

Canadian Bioceutical is still undervalued, says Echelon Wealth Partners

A new partnership for Canadian Bioceutical (CSE:BCC) is being commended by Echelon Wealth Partners analyst Russell Stanley. This morning, Canadian Bioceutical announced a joint venture with Israeli pharma company Panaxia that will see the pair partner on the sale of products such as sublingual tab ...